Related Experiment Video
Updated: Jul 18, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses
Diana Mechtcheriakova1, Alexander Wlachos, Jury Sobanov
1Novartis Institutes for BioMedical Research, Vienna, Brunnerstrasse 59, A-1235 Vienna, Austria. diana.mechtcheriakova@novartis.com
Inflammatory stimuli upregulate S1P phosphatase 2 (SPP2) in various cells. This NF-kappaB-dependent gene plays a pro-inflammatory role, as evidenced by its increased expression in psoriasis and its impact on cytokine production.
Area of Science:
- Cellular biology
- Molecular biology
- Immunology
Background:
- Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator.
- S1P levels are regulated by synthesis and degradation enzymes.
- Inflammatory conditions can alter S1P metabolism.
Purpose of the Study:
- To investigate the expression patterns of S1P-metabolizing enzymes under inflammatory conditions.
- To elucidate the regulatory mechanisms of S1P phosphatase 2 (SPP2) gene expression.
- To determine the role of SPP2 in inflammatory signalling.
Main Methods:
- Analysis of mRNA expression of sphingosine kinases, S1P phosphatases, and S1P lyase.
- Cell-type specific expression analysis of sphingosine kinase type 1 (SPHK1).
- NF-kappaB binding site analysis and siRNA-mediated silencing of NF-kappaB/RelA to study SPP2 regulation.
- Assessment of SPP2 function by silencing its expression in endothelial cells and measuring cytokine levels.
- Analysis of SPP2 expression in lesional skin from psoriasis patients.
Main Results:
- SPHK1 mRNA expression is cell-type specific.
- SPP2 expression and activity are significantly upregulated by inflammatory stimuli in multiple cell types.
- SPP2 is an NF-kappaB-dependent gene.
- Silencing SPP2 reduces TNF-alpha-induced IL-1beta and IL-8 production in endothelial cells.
- SPP2 is upregulated in psoriatic skin lesions.
Conclusions:
- SPP2 is a key enzyme in S1P metabolism that is upregulated during inflammation.
- SPP2 acts as a pro-inflammatory mediator by influencing cytokine production.
- SPP2 is regulated by NF-kappaB signalling.
- SPP2 represents a potential therapeutic target in inflammatory diseases like psoriasis.
Related Concept Videos
IP3/DAG Signaling Pathway
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Acute Inflammation II: Cellular Phase
Amplifying Signals via Second Messengers
What are Second Messengers?
The JAK-STAT Signaling Pathway
